Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Dec 11, 2020 6:59pm
51 Views
Post# 32091460

RE:Phizer and Moderna expected to earn 32 billion from vaccines

RE:Phizer and Moderna expected to earn 32 billion from vaccinesPfizer vaccine alone will likely end up selling close to $14 billion worth worldwide in 2021, according to Damien Conover, the director of health care equity research and equity strategy at the firm Morningstar. Conover noted that this Morningstar calculation is based on the assumption that the company will manufacture a billion doses of their vaccine, and have it fully approved in the late first quarter or early second quarter of next year (after emergency use in late 2020).
bligicka wrote: Such a shame that Goren is so slow to execute ....once in a lifetime opportunity and he's taking an extra 6 weeks to make a new batch of Corvax between experiments.....Shame !!!


<< Previous
Bullboard Posts
Next >>